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“CHARGE syndrome” is a complex syndrome with high and extremely variable
comorbidity. As a result, clinicians may struggle to provide accurate and comprehen-
sive care, and this has led to the publication of several clinical surveillance guidelines
and recommendations for CHARGE syndrome, based on both single case observations
and cohort studies. Here we perform a structured literature review to examine all the
existing advice. Our findings provide additional support for the validity of the recently
published Trider checklist. We also identified a gap in literature when reviewing all
guidelines and recommendations, and we propose a guideline for neuroradiological
evaluation of patients with CHARGE syndrome. This is of importance, as patients with
CHARGE are at risk for peri-anesthetic complications, making recurrent imaging
procedures under anesthesia a particular risk in clinical practice. However,
comprehensive cranial imaging is also of tremendous value for timely diagnosis,
proper treatment of symptoms and for further research into CHARGE syndrome. We
hope the guideline for neuroradiological evaluationwill help clinicians provide efficient
and comprehensive care for individuals with CHARGE syndrome.
K E YWORD S
CHARGE syndrome, CHD7, CT, guidelines, MRI
1 | INTRODUCTION
CHARGEsyndrome isa relatively frequentlyoccurring genetic syndrome
withanestimated incidenceof 1 in15,000. It is a very complex syndrome
with a broad phenotype that can involve almost all organ and sensory
systems. As a result, comorbidity is high and extremely variable. There is
also a striking variability in severity, with both verymild cases and severe
early lethal cases going undiagnosed. The clinical challenge of such a
complex disorder is that some clinical problemsmay remain undiagnosed
as other more severe or even life-threatening complications consume all
medical attention. The diverse clinical aspects of CHARGE syndrome
have been studied by several groups worldwide, resulting in extremely
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in
any medium, provided the original work is properly cited and is not used for commercial purposes.
© 2017 The Authors. American Journal of Medical Genetics Part C Published by Wiley Periodicals, Inc.
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useful guidelines and recommendations. For this special issue of the
American Journal of Medical Genetics (part C), we have examined these
guidelinesbyperforming a structured literature search and reviewing the
existing advice, including that of hallmark papers by Blake et al. (1998)
and the clinical checklist published recently by Trider (see Figure 1,
(Trider, Arra-Robar, van Ravenswaaij-Arts, & Blake, 2017)).
To date, no guidelines for cranial imaging in CHARGE syndrome
have been published, but we see two important reasons why there is a
need for such a guideline. First, in our experience and that of others,
cranial imaging in individuals with CHARGE syndrome is often
performed incompletely or with insufficient resolution. As a result,
some of the cranial malformations occurring in CHARGE syndrome
FIGURE 1 The Trider checklist. Republished (with permission) from Trider C-L, Arra-Robar A, van Ravenswaaij-Arts C, Blake K. 2017. Developing a
CHARGE syndrome checklist: Health supervision across the lifespan (from head to toe). American Journal of Medical Genetics Part A, 173A, 684–691. A PDF
of the checklist is available for download from https://www.chargesyndrome.org/wp-content/uploads/2016/03/CHARGE-Syndrome-Checklist.pdf
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were noted first in animal models (e.g., cerebellar abnormalities
(Yu et al., 2013)) or were found only after structured evaluation of
images of a series of individuals (Hoch et al., 2017). Second, as
individuals with CHARGE syndrome are at increased risk of post-
operative airway complications, procedures under anesthesia should
be combined as much as possible (Blake et al., 2009). The need to
improve imaging while reducing risks therefore warrants guidelines for
performing neuro-imaging in an optimal and efficient way. Altogether,
we argue that standardized recommendations for neuro-imaging
protocols could contribute to clinical awareness of the heterogeneous
cranial abnormalities involved in CHARGE syndrome and improve care.
2 | OVERVIEW OF GUIDELINES AND
RECOMMENDATIONS FROM LITERATURE
A literature search using PubMed was performed on August 17, 2017
using the search string: (“CHARGEsyndrome”OR “CHARGEassociation”
OR CHD7) AND (guideline* OR consensus OR recommend* OR “best
practice” OR “surveillance”). This resulted in 112 hits, of which 42
contained usable guidelines or recommendations. A further 15 articles
withguidelinesor recommendationswere found throughanexamination
of the references. The resulting full list with recommendations is given in
Supplemental Table S1. We then categorized the guidelines and
recommendations from the literature either by organ system or as
“general” (see Table 1), then checked if they were included in the Trider
checklist (see Figure 1 and Table 1).
Out of 73 formulated recommendations, 53 were covered by the
Trider checklist or the accompanying paper. Of the other 20, only one
is truly “missing” from the checklist: 12 were out of the scope of a
clinical surveillance checklist, six were too detailed to be included, and
one was a recommendation to not perform a test (adrenal evaluation).
The missing recommendation concerns the advice to parents,
therapists and teachers to take into account visual field defects. A
last recommendation was actually given in the Trider paper but not
included in their checklist. Trider advises screening patients with
TABLE 2 Recommendations from literature regarding CHD7 analysis
Recommendation Basis for recommendation References
The indication for CHD7 analysis can be determined
through the flow diagram provided by Bergman
et al.
Validated on cohort of 280 patients Bergman, Janssen, et al.
(2011)
CHD7 testing can confirm uncertain diagnosis in mildly
affected patients
Validated on cohorts of 280 and 28 patients Bergman, Janssen, et al.
(2011); Hale, Niederriter,
Green, and Martin (2016)
If a parent has any features of CHARGE syndrome,
molecular genetic testing is appropriate if a CHD7
pathogenic variant has been identified in the
proband
Case series of five families Jongmans et al. (2008)
A genome-wide array should be performed in patients
with CHARGE syndrome but without a CHD7
mutation
Expert opinion Corsten-Janssen et al.
(2013)
There is a very low yield of MLPA analysis in patients
with CHARGE syndrome but without causal CHD7
mutations
Cohort of 54 patients: 1 deletion of multiple exons;
several case reports
Bergman et al. (2008);
Wincent et al. (2008);
Wincent et al. (2009)
CHD7 analysis should be performed in patients with a
22q11.2 deletion phenotype without TBX1
haploinsufficiency
5 CHD7 mutations in 20 patients Corsten-Janssen et al.
(2013)
CHD7 analysis should be performed in patients with
Kallmann syndrome who have at least two
additional CHARGE features or semicircular canal
anomalies
Yield of 6% in (2 studies combined) 96 patients with
Kallmann syndrome/normosmic idiopathic
hypogonadotropic hypogonadism; hearing loss
enriched in probands with Kallmann syndrome and
CHD7 mutation vs. without CHD7 mutation
Bergman et al. (2012);
Costa-Barbosa et al.
(2013); Jongmans et al.
(2009)
CHD7 should be included in massive parallel
sequencing gene panels for diagnostics in patients
with syndromic heart defects
Expert opinion Corsten-Janssen et al.
(2014)
CHD7 analysis should not be performed routinely in
patients with isolated atrial septal or conotrunctal
heart defects
Cohort of 46 patients, no CHD7 mutations Corsten-Janssen et al.
(2014)
CHD7 analysis should not be performed in patients
with septo-optic dysplasia or hypopituitarism
without features of CHARGE syndrome
Cohort of 100 patients, no CHD7 mutations Gregory et al. (2013)
MLPA, multiplex ligation-dependent probe amplification; TBX1, T-box 1 gene.




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































DE GEUS ET AL. | 457
CHARGE for cochlear implant surgery before the age of three,
however the cochlear implant box in their checklist is not shaded for
the “infancy” column. Our review indicates the Trider surveillance
checklist is well-supported by literature with only minor omissions.
Recommendations regarding analysis for CHD7, the causative gene
for CHARGE syndrome, are beyond the scope of the clinical checklist
aimed at follow-up, but we have included a summary of these
guidelines in Table 2.
Aswe discussed in the introduction, there are currently no formal
guidelines for cranial imaging even though we argue that cranial
imaging is an important clinical tool that needs to be handled
carefully. The guidelines we present here for cranial imaging in
patients with CHARGE syndrome are based on previously published
neuro-radiologic recommendations (Asakura et al., 2008; Bergman,
Janssen, et al., 2011; Fujita et al., 2009; Gregory et al., 2013; Pinto
et al., 2005; Vesseur, Free, et al., 2016) in addition to current insights
in detectable neuro-radiologic abnormalities and anatomic variants in
patients with CHARGE syndrome (see Table 3).
3 | DIAGNOSTIC VALUE OF CRANIAL
IMAGING
Imaging of the semicircular canals is recommended in patientswith an
atypical presentation of the syndrome to decide whether CHD7
testing is warranted, or to confirm the clinical diagnosis when CHD7
testing reveals no or an unclassified variant (Bergman, Janssen, et al.,
2011). This is because aplasia or hypoplasia of the semicircular canals
is present in 95% of individuals with a pathogenic variant in the CHD7
gene, making it one of its most prevalent clinical features (Abadie
et al., 2000; Bauer, Goldin, & Lusk, 2002; Lemmerling et al., 1998;
Morimoto et al., 2006; Tellier et al., 1998; Wiener-Vacher, Amanou,
Denise, Narcy, &Manach, 1999). The configuration of the labyrinth in
CHARGE syndrome is typical: a malformed vestibule and aplastic or
hypoplastic semicircular canals that is sometimes combined with
cochlear malformation. These abnormalities can already be seen in
fetal imaging (Tilea et al., 2006) and can, on their own, provide a
valuable first clue toward diagnosis.
Arhinencephaly is another common feature inCHARGE syndrome
(Legendre et al., 2012; Sanlaville et al., 2006) that can be observed in
imaging. The olfactory nerves may be hypo- or aplastic, usually in
combination with olfactory sulcus effacement. Other cranial nerves,
particularly the facial and acoustic nerve,may also be hypo- or aplastic.
Hoch et al. (2017) recently published findings from MRI of the
head and neck for 10 individuals with CHARGE syndrome and noted
that skull base abnormalities (9/10) were often present in addition to
semicircular canal abnormalities (10/10) and hypoplasia of the
olfactory system (10/10). These skull base anomalies consisted of a
J-shaped sella and a dorsal angulation of the clivus. These findings
confirm the findings of Fujita et al. (2009) and are consistent with the
preliminary results of a study in which we analyzed the clivus of 23
confirmed patients with CHARGE onMRI or CT scans.We found that





















































































































































































































































































































































































































































































































































































































































































































458 | DE GEUS ET AL.
data]. These observations thus suggest that clivus abnormalities may
be used as an important additional diagnostic tool.
Lastly, orbital abnormalities such as microphthalmia and colobo-
mata, and nasal abnormalities such as choanal atresia may also be seen
on cranial MRI.
As summarized in Table 3, there are multiple features observable
on cranial MRI or CT that can aid in clinical diagnosis of CHARGE
syndrome. These include semicircular canal hypoplasia, hypo- or
aplasia of the olfactory nerve and sulcus, other cranial nerve hypo- or
aplasias, clivus abnormalities, colobomata, and choanal atresia.
4 | VALUE OF CRANIAL IMAGING IN
TREATMENT AND MANAGEMENT
4.1 | Hearing loss
Sixty to eighty percent of patients with CHARGE syndrome have
moderate to severe hearing loss, either conductive, sensorineural,
or mixed (Blake, Hartshorne, Lawand, Dailor, & Thelin, 2008).
Auditory testing combined with the findings on CT and MRI are
necessary for (i) diagnosing the type of hearing loss; (ii) choosing
the optimal kind of rehabilitation; and (iii) planning a (possible)
cochlear implantation (CI) or auditory brain stem implantation
(ABI). CT and MRI provide complementary information in this
situation: the bony anatomy is best studied on CT, while MRI
provides additional information about the inner ear and allows
visualization of the vestibulocochlear nerve.
Middle ear pathology, such as dysplastic ossicles or an absent/
stenotic oval or round window, is seen on mastoid CT in over 70% of
patients (Vesseur, Verbist, et al., 2016). In some of these children a
bone-anchored hearing aid (BAHA, sometimes known as BCD—bone
conductive device) may be a good hearing solution. A BAHA allows the
perception of sound by by-passing the middle ear, provided the
cochlea and auditory nerve are intact (Reinfeldt, Hakansson, Taghavi,
& Eeg-Olofsson, 2015). Cochlear nerve hypoplasia or aplasia is seen
relatively frequently in CHARGE (Holcomb, Rumboldt, &White, 2013),
which reduces the possibilities for CI. In these cases, auditory brain
stem implantationmay be an option, although hearing results appear to
be less successful while the surgery is more extensive than for CI
(Colletti, Colletti, Mandala, & Colletti, 2014).
CT imaging also provides additional information about surgical
landmarks for cochlear implantation, such as detailed information
about the lateral semicircular canals, which serves as a landmark for
mastoidectomy. Alternatively, an aberrant course of the facial nerve
increases the risk of perioperative injury and may impede cochle-
ostomy (Vesseur, Free, et al., 2016). Vascular abnormalities may also
hamper the surgical procedure. Vesseur, Free, et al. (2016) recently
published a guideline on CI implantation in CHARGE that extensively
covers preoperative imaging.
4.2 | Olfactory bulbs and puberty induction
Fetal studies found arhinencephaly in 36 of 40 (90%) fetuses with a
confirmed pathogenic CHD7 variant (Legendre et al., 2012). This is
seen less often postnatally, although anosmia is diagnosed in
approximately 80% of individuals with CHARGE syndrome
(Bergman, Bocca, et al., 2011). Bergman, Bocca, et al. (2011) showed
that olfaction and spontaneous onset of puberty are correlated in
CHARGE syndrome: all (11/11) patients with hypogonadotropic
hypogonadism (HH) were unable to smell, whereas patients without
HH had the ability to smell (4/4). This combination of symptoms is
also seen in Kallmann syndrome and is explained by common factors
that facilitate axon guidance for both olfactory and GnRH neurons
(Yanicostas, Herbomel, Dipietromaria, & Soussi-Yanicostas, 2009).
The correlation of anosmia and HH enables prediction of HH in
patients with CHARGE experiencing anosmia, which is useful
because after the age of 3 months endocrinological assessment of
HH is impossible until the onset of puberty. Therefore, in children for
whom no endocrinological evaluation was performed before the age
of 3 months, anosmia can help predict whether it will be necessary to
induce puberty. As the formal evaluation of sense of smell is fairly
involved and only possible from a (developmental) age of 5 years,
and an impaired sense of smell can have many causes, radiological
evidence of olfactory nerve/bulb aplasia or hypoplasia can aid in
FIGURE 2 Clivus abnormalities in CHARGE syndrome. Normal anatomy (left) and typical CHARGE clivus in a 22-month-old boy (right). The
clivus and sphenobasion have been outlined in yellow with the clivus indicated with red lines
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predicting patients at risk for HH. However, because olfactory
imaging is not a perfect predictor of sense of smell, olfactory imaging
alone is insufficient to determine HH status.
4.3 | Other brain abnormalities
MR imaging has revealed a variety of other brain abnormalities in
CHARGEsyndrome (Hochet al., 2017). In specific cases, the presenceof
brain abnormalities on MRI can explain a particular clinical feature in a
patient. For instance, post-asphyxia damage may explain an otherwise
unexpected severe developmental delay in a child with overall mild
symptoms. However, predicting clinical symptoms fromMRI abnormal-
ities is more difficult. For instance, even though cerebellar dys- or
hypoplasia is fairly common in CHARGE syndrome (Yu et al., 2013), no
relationship to ataxia has been reported so far (Sohn et al., 2016).
Research on the clinical relevance of cerebellar anomalies is ongoing.
FIGURE 3 Guideline for CT and MR imaging in CHARGE syndrome
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5 | RESEARCH AND CRANIAL IMAGING
Since the identification of CHD7 as the causal gene for CHARGE
syndrome, several animal models have been developed, with mouse
models being themost-studied. This has led to the identification inmice
of significant anatomical features that were not known or were only
anecdotally described in individuals with CHARGE syndrome. The best
example for this is the hypoplasia of the cerebellar vermis.Abnormalities
of the cerebellum were sporadically mentioned in papers on CHARGE
syndrome, but it was only after the identification in mice of a role for
Chd7 in the isthmic organizer that a systemic study of humanMRI scans
revealed cerebellar abnormalities in at least half of individuals with
CHARGE syndrome (Haldipur & Millen, 2013; Yu et al., 2013).
Jiang et al. (2012) described telencephalic midline abnormalities in
a mouse model with a nonsense Chd7 mutation. These mice had
arhinencephaly, dilated third and lateral ventricles, reduced cerebral
cortex, and corpus callosum crossing failure. As described above,
arhinencephaly is a well-known CHARGE feature, but it was not until
recently that ventriculomegaly and corpus callosum abnormalities
were described in patients with CHARGE (Hoch et al., 2017; Jiang
et al., 2012).
Sperry et al. (2014) found several phenotypic features that are
well-known in humans with CHARGE syndrome in Foxg1 and Wnt1
conditional knockout mice, but they also observed skull bone
abnormalities such as frontal, parietal and occipital bone dysplasia
and hypoplasia of the maxilla (Sperry et al., 2014). The same
abnormalities were not seen in heterozygous Chd7 mice and have
not been described in humans, but as described above, clivus and
petrosal abnormalities are common in individuals with CHARGE
syndrome.
Inner and middle ear abnormalities (os petrosum) have been
studied extensively in humans and mice because of their effect on
hearing. Therefore, most anatomic anomalies seen in Chd7-deficient
mice had already been extensively documented in individuals with
CHARGE syndrome. One lesser-known feature, however, is the
otosclerosis-like fusion of the stapes footplate to the cochlear oval
window as described by Ogier et al. (2014) in Looper mice. A recent
study of CT images of the os petrosum of individuals with CHARGE
syndrome showed that, in addition to the (known) abnormalities of
the oval window, the stapes was dysplastic or not identifiable in half
of the ears with a stenotic oval window (Vesseur, Verbist, et al.,
2016).
It is obvious that researchers studying animal models are
interested in translating their findings to humans. Performing MRI or
CT scans in children with CHARGE syndrome solely for the sake of
research is ethically difficult to accept, especially since most children
will have to be sedated with a risk of post-sedation respiratory
problems. However, when there is a clinical indication to perform
imaging studies, performing imaging as complete and as detailed as
possible aides both individuals with CHARGE syndrome through
better and more complete diagnosis and researchers through a
better and more complete picture of the features of CHARGE
syndrome.
6 | GUIDELINE FOR CRANIAL IMAGING
In our experience, in each individual with CHARGE, a wide variety of
scans are usually performed by different medical specialists. This leads
to scans that differ in completeness and sequences used. A further
complication is that scans are often performed in different hospitals
and parents may find it difficult to recall if and where imaging was
done, illustrating that the early years of children with CHARGE
syndrome are often hectic and overwhelming.
Individuals with CHARGE syndrome often undergo a great many
procedures under anesthesia (Blake et al., 2009). To reduce the risk of
recurrent anesthesia and minimize exposure to radiation, neuro-
imaging should preferentially be completed within one efficient
session. With that objective in mind, a radiology guideline, combining
CT andMRI scanning and outlining the correct sequences, may enable
accurate diagnostic radiologic assessment of the cranial and auditory
anatomy within one session. This guideline is presented in Figure 3. In
children up to 6months of age, the unnecessary risk of anesthesia may
be avoided by swaddling (CT duration 0.5–2min, MRI duration
approximately 30min). In our opinion, avoidance of unnecessary
anesthesia is more important than the small chance of movement
artifacts in the MRI of a swaddled infant.
7 | CONCLUSION
CHARGE syndrome is a complex entity with a wide range of congenital
abnormalities and clinical symptoms. The multitude of issues that
individualswithCHARGEsyndrome face,particularlyearly in life, greatly
increases the risk that their care will be fragmented or incomplete. Our
review confirms that the Trider checklist provides a well-supported
framework for clinical surveillance. Our guideline for cranial imaging
provides an aid to clinicians for providing accurate and optimal care
while limiting risky anesthetic procedures, and may enable more
effective research into cranial abnormalities in CHARGE syndrome.
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